SK teams up with MSD Korea over losartan

Published: 2008-04-28 06:57:00

Updated: 2008-04-28 06:57:00

SK Chemicals and MSD Korea entered into an agreement to conduct the joint marketing of COSKAR PLUS and COSKAR PLUS F on April 24.

COSKAR PLUS and COSKAR PLUS F contain losartan, which has been marketed by the tradename of Cozaar by MSD Korea.

The two medications are antihypertension medicat...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK